Title: Topical vitamin D₃ analogues induce thymic stromal lymphopoietin and cathelicidin in psoriatic skin lesions.
Journal: The British journal of dermatology 20120701
Title: Effects of rotation of topical vitamin D3 in chronic plaque-type psoriasis.
Journal: The Journal of dermatology 20120301
Title: Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis.
Journal: American journal of nephrology 20120101
Title: Verrucous skin lesions on the feet in diabetic neuropathy successfully treated with topical maxacalcitol.
Journal: European journal of dermatology : EJD 20120101
Title: A study of maintenance therapy after intravenous maxacalcitol for secondary hyperparathyroidism.
Journal: Clinical nephrology 20111001
Title: Formulation study of topically applied O/W lotion containing vitamin D3 derivative, focusing on skin permeability of the drug.
Journal: Drug development and industrial pharmacy 20110801
Title: Duration of remission period of narrowband ultraviolet B therapy on psoriasis vulgaris.
Journal: The Journal of dermatology 20110701
Title: Infantile acropustulosis treated successfully with topical maxacalcitol.
Journal: Acta dermato-venereologica 20110501
Title: 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.
Journal: Cancer 20101201
Title: Striate palmoplantar keratoderma.
Journal: The Journal of dermatology 20100901
Title: Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis.
Journal: Expert opinion on pharmacotherapy 20100701
Title: Effectiveness of weekly percutaneous maxacalcitol injection therapy in patients with secondary hyperparathyroidism.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20100201
Title: Contact immunotherapy-induced Renbök phenomenon in a patient with alopecia areata and psoriasis vulgaris.
Journal: European journal of dermatology : EJD 20100101
Title: Improvement of impaired calcium and skeletal homeostasis in vitamin D receptor knockout mice by a high dose of calcitriol and maxacalcitol.
Journal: Bone 20091101
Title: Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090801
Title: Drug-induced acute pancreatitis associated with 22-oxacalcitriol ointment for treatment of psoriasis.
Journal: JOP : Journal of the pancreas 20090518
Title: Clinical usefulness of a supplementary cyclosporin administration with a topical application of maxacalcitol ointment for patients with moderate psoriasis vulgaris.
Journal: The Journal of dermatology 20090401
Title: Type 2 segmental manifestation of disseminated superficial actinic porokeratosis in a 7-year-old girl.
Journal: European journal of dermatology : EJD 20090101
Title: A bivariate autoregressive linear mixed effects model for the analysis of longitudinal data.
Journal: Statistics in medicine 20081230
Title: Aza- and oxadithiolates are probable proton relays in functional models for the [FeFe]-hydrogenases.
Journal: Journal of the American Chemical Society 20081217
Title: A case of mosaic-type bullous congenital ichthyosiform erythroderma successfully treated with topical maxacalcitol, a vitamin D3 analogue.
Journal: Clinical and experimental dermatology 20080701
Title: Cutaneous pharmacokinetics of topically applied maxacalcitol ointment and lotion.
Journal: International journal of clinical pharmacology and therapeutics 20080601
Title: Molecular and morphological approach of uremia-induced hyperplastic parathyroid gland following direct maxacalcitol injection.
Journal: Medical molecular morphology 20080601
Title: Efficacy of high-concentration tacalcitol ointment in psoriasis vulgaris after changing from other high-concentration vitamin D3 ointments.
Journal: Dermatology online journal 20080227
Title: Clinical effect of vitamin D3 analogues is not inactivated by subsequent UV exposure.
Journal: Photodermatology, photoimmunology & photomedicine 20080201
Title: Direct injection of calcitriol or its analog improves abnormal gene expression in the hyperplastic parathyroid gland in uremia.
Journal: American journal of nephrology 20080101
Title: Vitamin D and the digestive system.
Journal: European journal of drug metabolism and pharmacokinetics 20080101
Title: Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment.
Journal: International journal of dermatology 20071201
Title: Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20070801
Title: Analysis of in vitro skin permeation of 22-oxacalcitriol from ointments based on a two- or three-layer diffusion model considering diffusivity in a vehicle.
Journal: International journal of pharmaceutics 20070524
Title: An autoregressive linear mixed effects model for the analysis of longitudinal data which show profiles approaching asymptotes.
Journal: Statistics in medicine 20070430
Title: Binding of highly concentrated maxacalcitol to the nuclear vitamin D receptors of parathyroid cells.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070401
Title: Successful treatment of refractory warts with topical vitamin D3 derivative (maxacalcitol, 1alpha, 25-dihydroxy-22-oxacalcitriol) in 17 patients.
Journal: The Journal of dermatology 20070401
Title: Prospective comparison of the effects of maxacalcitol and calcitriol in chronic hemodialysis patients with secondary hyperparathyroidism: a multicenter, randomized crossover study.
Journal: Clinical nephrology 20070101
Title: Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease.
Journal: Drugs 20070101
Title: Comedolytic effect of topically applied active vitamin D3 analogue on pseudocomedones in the rhino mouse.
Journal: The British journal of dermatology 20061101
Title: Successful treatment of stucco keratosis with maxacalcitol.
Journal: The British journal of dermatology 20061101
Title: Comparison of the efficacy of calcipotriol and maxacalcitol in combination with narrow-band ultraviolet B therapy for the treatment of psoriasis vulgaris.
Journal: Photodermatology, photoimmunology & photomedicine 20061001
Title: Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism.
Journal: Kidney international 20060801
Title: Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells.
Journal: Kidney international. Supplement 20060701
Title: [Progress in research on vitamin D analogs].
Journal: Clinical calcium 20060701
Title: Design and evaluation of new antipsoriatic antedrug candidates having 16-en-22-oxa-vitamin D3 structures.
Journal: Bioorganic & medicinal chemistry letters 20060615
Title: Epidermodysplasia verruciformis and generalized verrucosis: the same disease?
Journal: Clinical and experimental dermatology 20060501
Title: Successful treatment of warts with a combination of maxacalcitol ointment and salicylic acid sticking plaster.
Journal: The Journal of dermatology 20060501
Title: Analysis of in vitro skin permeation of 22-oxacalcitriol having a complicated metabolic pathway.
Journal: Pharmaceutical research 20060401
Title: Is the volume of the parathyroid gland a predictor of Maxacalcitol response in advanced secondary hyperparathyroidism?
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20060401
Title: A case of maxacalcitol-resistant confluent and reticulated papillomatosis successfully treated with minocycline.
Journal: The Journal of dermatology 20060301
Title: No change in circulating osteoprotegerin levels by intravenous calcitriol therapy among dialysis patients with secondary hyperparathyroidism.
Journal: Clinical nephrology 20060201
Title: Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
Journal: Nephron. Clinical practice 20060101
Title: Treatment of psoriasis vulgaris with narrow-band UVB and topical Maxacalcitol.
Journal: Acta dermato-venereologica 20060101
Title: Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D3, maxacalcitol, on the proliferation of pancreatic cancer cell lines.
Journal: The Journal of steroid biochemistry and molecular biology 20051001
Title: Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients.
Journal: Clinical and experimental nephrology 20050901
Title: [Influence of serum phosphate level for effects of OCT pulse therapy in hyper-PTH HD patients].
Journal: Clinical calcium 20050901
Title: [Suitable examination intervals for hemodialysis patients with secondary hyperparathyroidism treated with maxacalcitol].
Journal: Clinical calcium 20050901
Title: [Acute response of serum PTH and bone markers after injection of 1alpha,25 (OH)2D3 and 22-oxacalcitrol in hemodialysis patient].
Journal: Clinical calcium 20050901
Title: Maxacalcitol is a possible less phosphatemic vitamin D analog.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050801
Title: Maxacalcitol therapy decreases circulating osteoprotegerin levels in dialysis patients with secondary hyperparathyroidism.
Journal: Clinical nephrology 20050701
Title: Assessment of therapeutic effect in patients with secondary hyperparathyroidism using bone scintigraphy.
Journal: Annals of nuclear medicine 20050701
Title: 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.
Journal: Carcinogenesis 20050601
Title: Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.
Journal: Clinical and experimental nephrology 20050601
Title: In vivo assessment of the cutaneous bioavailability of topically applied maxacalcitol.
Journal: Methods and findings in experimental and clinical pharmacology 20050601
Title: Measurement and characterization of C-3 epimerization activity toward vitamin D3.
Journal: Archives of biochemistry and biophysics 20050401
Title: The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolites.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050201
Title: Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.
Journal: Journal of the American Society of Nephrology : JASN 20050101
Title: Pharmacokinetics of calcitriol and maxacalcitol administered into peritoneal dialysate bags in peritoneal dialysis patients.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20050101
Title: [Therapy for ROD and measurement of the bone mass].
Journal: Clinical calcium 20041201
Title: Dose-response study of 22-oxacalcitriol in patients with secondary hyperparathyroidism.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20041201
Title: Adsorption of oxacalcitriol by polysulphone haemodialyser in patients with secondary hyperparathyroidism.
Journal: British journal of clinical pharmacology 20041101
Title: [Advantage of intravenous pulse therapy with calcitriol or maxacalcitol in dialysis patients with renal hyperparathyroidism].
Journal: Clinical calcium 20040901
Title: [Serum calcium concentration and the safety of vitamin D therapy].
Journal: Clinical calcium 20040901
Title: Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040801
Title: Chronopharmacology of oxacalcitriol in 5/6 nephrectomized rats.
Journal: Life sciences 20040702
Title: Avoidance of direct injury to the peripheral nerve with maxacalcitol (22oxa-1,25(OH)2D3) in rats.
Journal: Nephrology (Carlton, Vic.) 20040601
Title: Suppression of parathyroid hormone secretion in CAPD patients by intraperitoneal administration of Maxacalcitol.
Journal: Clinical and experimental nephrology 20040601
Title: [Parathyroid intervention and surgical treatment in renal hyperparathyroidism].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040601
Title: [The trend in the development of the active vitamin D3 and its analogues].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040501
Title: Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040401
Title: Chronopharmacology of oxacalcitriol in rat model of osteoporosis.
Journal: European journal of pharmacology 20040319
Title: Calcimimetics versus vitamin D: what are their relative roles?
Journal: Blood purification 20040101
Title: Receptor microscopic autoradiography for the study of percutaneous absorption, in vivo skin penetration, and cellular-intercellular deposition.
Journal: Journal of pharmacological and toxicological methods 20040101
Title: Intravenous vitamin D therapy reduces PTH-(1-84)/large C fragments ratio in chronic hemodialysis patients.
Journal: Nephron. Clinical practice 20040101
Title: Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20031201
Title: Anti-tumor effect of vitamin A and D on head and neck squamous cell carcinoma.
Journal: Auris, nasus, larynx 20031201
Title: Topical treatment with 22-oxacalcitriol (OCT), a new vitamin D analogue, caused severe hypercalcemia with exacerbation of chronic renal failure in a psoriatic patient with diabetic nephropathy; a case report and analysis of the potential for hypercalcemia.
Journal: Internal medicine (Tokyo, Japan) 20031201
Title: Development of hungry bone syndrome after rapid lowering of PTH with intravenous maxacalcitol therapy in a patient with non-uremic secondary hyperparathyroidism.
Journal: Clinical nephrology 20031101
Title: Effect of 22-oxacalcitriol on secondary hyperparathyroidism in hemodialysis patients.
Journal: Internal medicine (Tokyo, Japan) 20031001
Title: Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia.
Journal: Kidney international 20030901
Title: In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030901
Title: Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030601
Title: Time course of change in calcium x phosphorus product after percutaneous ethanol injection therapy.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030601
Title: Combined radioguided parathyroidectomy and intravenous vitamin D therapy for the treatment of uraemic hyperparathyroidism.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030601
Title: Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20030301
Title: Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation.
Journal: Journal of dermatological science 20030201
Title: Two novel metabolic pathways of 22-oxacalcitriol (OCT). C-25 dehydration and C-3 epimerization and biological activities of novel OCT metabolites.
Journal: The Journal of biological chemistry 20030117
Title: [Maxacalcitol, a medicine for secondary hyperparathyroidism (2 degrees HPT)].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20030101
Title: [Mechanism of uremic osteodystrophy and prevention of hyperparathyroidism in the uremic patient].
Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20030101
Title: Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells.
Journal: Nephron. Physiology 20030101
Title: The effect of intraperitoneal 22-oxacalcitriol on secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis patients (IPOX study).
Journal: Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 20030101
Title: Different effects of 22-oxacalcitriol and calcitriol on the course of experimental chronic renal failure.
Journal: The Journal of laboratory and clinical medicine 20021001
Title: Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
Journal: Leukemia 20020801
Title: 1Alpha25(OH)2D3 interferes with retinoic acid-induced inhibition of c-fos gene expression for AP-1 formation in osteoblastic cells.
Journal: Journal of oral science 20020301
Title: Effects of vitamin D analog, 22-oxa-1,25-dihydroxyvitamin D(3), on bone reconstruction by vascularized bone allograft.
Journal: Bone 20020201
Title: [The clinical evaluation of maxacalcitol on therapy for secondary hyperparathyroidism of chronic hemodialysis patients].
Journal: Nihon Jinzo Gakkai shi 20020101
Title: [A case with secondary hyperparathyroidism suggesting the direct suppressive effect of maxacalcitol on osteoblasts].
Journal: Nihon Jinzo Gakkai shi 20020101
Title: Vitamin D analogues for secondary hyperparathyroidism.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020101
Title: Effects of 1,25-dihydroxy-22-oxavitamin D(3) on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidism.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020101
Title: Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020101
Title: A comparison between daily and thrice-weekly i.v. administration of 1,25-dihydroxy-22-oxavitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action in uraemic rats.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020101
Title: A comparison between 1,25-dihydroxy-22-oxavitamin D(3) and 1,25-dihydroxyvitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020101
Title: Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in dogs with chronic renal failure.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020101
Title: In vivo time-course of receptor binding in the parathyroid gland of the vitamin D analogue [(3)H]1,25-dihydroxy-22-oxavitamin D(3) compared with [(3)H]1,25-dihydroxyvitamin D(3), determined by micro-autoradiography.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020101
Title: Clinical effects of maxacalcitol on secondary hyperparathyroidism of uremic patients.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20011001
Title: Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis.
Journal: Frontiers in bioscience : a journal and virtual library 20010701
Title: A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis.
Journal: The American journal of pathology 20010501
Title: Synthesis and evaluation of A-ring diastereomers of 1alpha,25-dihydroxy-22-oxavitamin D3 (OCT).
Journal: Bioorganic & medicinal chemistry 20010201
Title: History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2beta-(3-hydroxypropoxy)calcitriol (ED-71).
Journal: Steroids 20010101
Title: 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
Journal: Kidney international 19990301
Title: Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary study.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 19960101
Title: Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Journal: Endocrinology 19950101
Title: Hypocalcemia, regardless of the vitamin D status, decreases epidermal growth factor receptor density and autophosphorylation in rat livers.
Journal: Endocrinology 19930801
Title: Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolism.
Journal: Kidney international 19930301
Title: Effects of two new vitamin D3 derivatives, 22-oxa-1 alpha-25-dihydroxyvitamin D3 (OCT) and 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture.
Journal: Bone 19930101
Title: A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.
Journal: Endocrinology 19910801
Title: Barroga, et al. Inhibitory effects of 22-oxa-calcitriol and all-trans retinoic acid on the growth of a canine osteosarcoma derived cell-line in vivo and its pulmonary metastasis in vivo. Res.Vet.Sci. (2000)68 79.
Title: Monier-Faugere, et al. 22-Oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure. Kidney Int. (1999)55 821.
Title: Inoue K, et al. Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3.Lab Invest. 2012 Aug 27.
Title: Karashima T, et al. Successful Treatment of Bowen's Disease with Topical Maxacalcitol.Acta Derm Venereol. 2012 Jan 26.
